Supplementary files of the article "Structure-activity relationships reveal a 2-furoyloxychalcone as a potent cytotoxic and apoptosis inducer for human U-937 and HL-60 leukaemia cells" [Dataset]

Rosario, Henoc del; Saavedra, Ester; Brouard, Ignacio; González-Santana, Daniel; García Cortés, Celia; Spínola-Lasso, Elena; Tabraue, Carlos; Quintana, José; Estévez, Francisco

Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/311271

COMPARTIR / EXPORTAR:

SHARE BASE	Comparte tu historia de Acceso Abierto
Visualizar otros formatos: MARC \| Dublin Core \| RDF \| ORE \| MODS \| METS \| DIDL \| DATACITE
Refman EndNote Bibtex RefWorks Excel CSV PDF DataCite Send via email

Título:	Supplementary files of the article "Structure-activity relationships reveal a 2-furoyloxychalcone as a potent cytotoxic and apoptosis inducer for human U-937 and HL-60 leukaemia cells" [Dataset]
Autor:	Rosario, Henoc del; Saavedra, Ester; Brouard, Ignacio CSIC ORCID ; González-Santana, Daniel; García Cortés, Celia; Spínola-Lasso, Elena; Tabraue, Carlos; Quintana, José CSIC ORCID; Estévez, Francisco CSIC ORCID
Fecha de publicación:	oct-2022
Editor:	Academic Press Elsevier
Citación:	Rosario, Henoc del; Saavedra, Ester; Brouard, Ignacio; González-Santana, Daniel; García Cortés, Celia; Spínola-Lasso, Elena; Tabraue, Carlos; Quintana, José; Estévez, Francisco; Supplementary files of the article "Structure-activity relationships reveal a 2-furoyloxychalcone as a potent cytotoxic and apoptosis inducer for human U-937 and HL-60 leukaemia cells" [Dataset]; Academic Press; Elsevier; https://doi.org/10.1016/j.bioorg.2022.105926
Descripción:	Figure S1: 1H-NMR (500 MHz, CDCl3) Spectrum of Compound 1 Figure S2: 13C-NMR (125 MHz, CDCl3) Spectrum of Compound 1 Figure S3: ESI-MS Spectrum of Compound 1 Figure S4: HRHRESI-MS Spectrum of Compound 1 Figure S5: 1H-NMR (500 MHz, CDCl3) Spectrum of Compound 2 Figure S6: 13C-NMR (125 MHz, CDCl3) Spectrum of Compound 2 Figure S7: ESI-MS Spectrum of Compound 2 Figure S8: HRESI-MS Spectrum of Compound 2 Figure S9: 1H-NMR (400 MHz, CDCl3) Spectrum of Compound 3 Figure S10: 13C-NMR (101 MHz, CDCl3) Spectrum of Compound 3 Figure S11: ESI-MS Spectrum of Compound 3 Figure S12: HRESI-MS Spectrum of Compound 3 Figure S13: 1H-NMR (400 MHz, CDCl3) Spectrum of Compound 4 Figure S14: 13C-NMR (101 MHz, CDCl3) Spectrum of Compound 4 Figure S15: ESI-MS Spectrum of Compound 4 Figure S16: HRESI-MS Spectrum of Compound 4 Figure S17: 1H-NMR (400 MHz, CDCl3) Spectrum of Compound 5 Figure S18: 13C-NMR (101 MHz, CDCl3) Spectrum of Compound 5 Figure S19: ESI-MS Spectrum of Compound 5 Figure S20: HRESI-MS Spectrum of Compound 5 2 Figure S21: 1H-NMR (500 MHz, CDCl3) Spectrum of Compound 6 Figure S22: 13C-NMR (126 MHz, CDCl3) Spectrum of Compound 6 Figure S23: ESI-MS Spectrum of Compound 6 Figure S24: HRESI-MS Spectrum of Compound 6 Figure S25: 1H-NMR (400 MHz, CDCl3) Spectrum of Compound 7 Figure S26: 13C-NMR (101 MHz, CDCl3) Spectrum of Compound 7 Figure S27: ESI-MS Spectrum of Compound 7 Figure S28: HRESI-MS Spectrum of Compound 7 Figure S29: 1H-NMR (400 MHz, CDCl3) Spectrum of Compound 8 Figure S30: 13C-NMR (101 MHz, CDCl3) Spectrum of Compound 8 Figure S31: ESI-MS Spectrum of Compound 8 Figure S32: HRESI-MS Spectrum of Compound 8 Figure S33: 1H-NMR (500 MHz, CDCl3) Spectrum of Compound 9 Figure S34: 13C-NMR (126 MHz, CDCl3) Spectrum of Compound 9 Figure S35: ESI-MS Spectrum of Compound 9 Figure S36: HRESI-MS Spectrum of Compound 9 Figure S37: 1H-NMR (500 MHz, CDCl3) Spectrum of Compound 10 Figure S38: 13C-NMR (126 MHz, CDCl3) Spectrum of Compound 10 Figure S39: ESI-MS Spectrum of Compound 10 Figure S40: HRESI-MS Spectrum of Compound 10 Figure S41: 1H-NMR (400 MHz, CDCl3) Spectrum of Compound 11 Figure S42: 13C-NMR (101 MHz, CDCl3) Spectrum of Compound 11 Figure S43: ESI-MS Spectrum of Compound 11 Figure S44: HRESI-MS Spectrum of Compound 11 Figure S45: 1H-NMR (400 MHz, CDCl3) Spectrum of Compound 12 Figure S46: 13C-NMR (101 MHz, CDCl3) Spectrum of Compound 12 Figure S47: ESI-MS Spectrum of Compound 12 Figure S48: HRESI-MS Spectrum of Compound 12 Figure S49: 1H-NMR (400 MHz, CDCl3) Spectrum of Compound 13 Figure S50: 13C-NMR (101 MHz, CDCl3) Spectrum of Compound 13 Figure S51: ESI-MS Spectrum of Compound 13 Figure S52: HRESI-MS Spectrum of Compound 13 Figure S53: 1H-NMR (400 MHz, CDCl3) Spectrum of Compound 14 Figure S54: 13C-NMR (101 MHz, CDCl3) Spectrum of Compound 14 Figure S55: ESI-MS Spectrum of Compound 14 Figure S56: HRESI-MS Spectrum of Compound 14
Versión del editor:	https://doi.org/10.1016/j.bioorg.2022.105926
URI:	http://hdl.handle.net/10261/311271
DOI:	10.1016/j.bioorg.2022.105926
Referencias:	Rosario, Henoc del; Saavedra, Ester; Brouard, Ignacio; González-Santana, Daniel; García Cortés, Celia; Spínola-Lasso, Elena; Tabraue, Carlos; Quintana, José; Estévez, Francisco. Supplementary files of the article Structure-activity relationships reveal a 2-furoyloxychalcone as a potent cytotoxic and apoptosis inducer for human U-937 and HL-60 leukaemia cells [Dataset]. 10.1016/j.bioorg.2022.105926. http://hdl.handle.net/10261/282565
Aparece en las colecciones:	(IBGM) Conjuntos de datos